Eagle Pharmaceuticals
EGRX
#10434
Rank
HK$38.37 M
Marketcap
HK$2.96
Share price
0.00%
Change (1 day)
-41.48%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$38.37 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of HK$38.37 Million. This makes Eagle Pharmaceuticals the world's 10434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$38.37 M-15.41%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$38.37 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$3.838 T 10,000,371.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$793.77 B 2,068,094.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$2.116 T 5,515,311.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
HK$286.24 B 745,707.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$1.368 T 3,565,985.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.431 T 19,362,434.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$886.34 B 2,309,287.82%๐Ÿ‡บ๐Ÿ‡ธ USA